Skip to main content
OrthoVellum
Knowledge Hub

Study

  • Topics
  • MCQs
  • ISAWE
  • Operative Surgery
  • Flashcards

Company

  • About Us
  • Editorial Policy
  • Contact
  • FAQ
  • Blog

Legal

  • Terms of Service
  • Privacy Policy
  • Cookie Policy
  • Medical Disclaimer
  • Copyright & DMCA
  • Refund Policy

Support

  • Help Center
  • Accessibility
  • Report an Issue
OrthoVellum

Ā© 2026 OrthoVellum. For educational purposes only.

Not affiliated with the Royal Australasian College of Surgeons.

Oncology
intermediate
X-Type

Giant Cell Tumor Management

Bone Tumors

A 32-year-old woman presents with progressive knee pain over 3 months. She has no history of trauma or systemic symptoms. Examination reveals a palpable swelling around the medial femoral condyle. X-rays show an eccentrically located lytic lesion in the distal femoral epiphysis extending to the subchondral bone with well-defined but non-sclerotic margins. MRI confirms the lesion and shows no soft tissue extension. Regarding giant cell tumor of bone:

Mark each as TRUE or FALSE

A

Giant cell tumor (GCT) is a benign but locally aggressive tumor representing 5% of primary bone tumo...

B

Radiographic appearance is an eccentrically located, lytic lesion in the epiphysis/metaphysis with w...

C

GCT most commonly occurs in children before skeletal maturity; it affects the diaphysis; it has scle...

D

Treatment of Grade 1-2 GCT is extended intralesional curettage with local adjuvants (phenol, liquid ...

E

Denosumab (RANKL inhibitor) can be used neoadjuvantly to shrink tumor and create a peripheral rim of...

Answer the questions to see explanations

Click T (True) or F (False) for each option